STARmed is Korean medical device manufacturer that
has focused only on tumor treatment using radiofrequency technology
for more than a decade.

Our technology has been developed through close collaboration with clinical experts. Our innovative RFA technology is used in the treatment of multiple indications including liver and thyroid tumors.

We continue to research and develop new devices with our RFA technology to help patients around the globe.

As the Global Leader of Thyroid RFA, we continue to prove the superiority of our products with over 250 articles and 20+ patents worldwide.

STARmed will strive for innovation in RFA technology and continue to improve the quality of patient’s lives.